MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 91 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $333,110 | +239.0% | 1,189 | +223.1% | 0.16% | +213.5% |
| Q1 2024 | $98,271 | +7.0% | 368 | -7.3% | 0.05% | -10.3% |
| Q4 2023 | $91,858 | +62.1% | 397 | +2.3% | 0.06% | +70.6% |
| Q3 2023 | $56,664 | -42.1% | 388 | -8.5% | 0.03% | -41.4% |
| Q2 2023 | $97,944 | -76.7% | 424 | -75.5% | 0.06% | -74.9% |
| Q1 2023 | $419,837 | -39.7% | 1,733 | -27.8% | 0.23% | -36.5% |
| Q4 2022 | $696,310 | +603.3% | 2,399 | +57.9% | 0.36% | +833.3% |
| Q3 2022 | $99,000 | -8.3% | 1,519 | +1.0% | 0.04% | -2.5% |
| Q2 2022 | $108,000 | -48.6% | 1,504 | -29.7% | 0.04% | -57.4% |
| Q1 2022 | $210,000 | +9.4% | 2,139 | -5.8% | 0.09% | +28.8% |
| Q4 2021 | $192,000 | +21.5% | 2,270 | +14.9% | 0.07% | +4.3% |
| Q3 2021 | $158,000 | -21.8% | 1,976 | -4.9% | 0.07% | -15.7% |
| Q2 2021 | $202,000 | -30.3% | 2,078 | -16.2% | 0.08% | -32.0% |
| Q1 2021 | $290,000 | +6.6% | 2,480 | +1.5% | 0.12% | +8.0% |
| Q4 2020 | $272,000 | -20.5% | 2,444 | -15.1% | 0.11% | -36.9% |
| Q3 2020 | $342,000 | -8.1% | 2,879 | -12.4% | 0.18% | +1.7% |
| Q2 2020 | $372,000 | +51.2% | 3,287 | -10.8% | 0.18% | +74.3% |
| Q1 2020 | $246,000 | -36.1% | 3,683 | -12.8% | 0.10% | +60.3% |
| Q4 2019 | $385,000 | +71.9% | 4,226 | +62.5% | 0.06% | +40.0% |
| Q3 2019 | $224,000 | -22.2% | 2,600 | -5.2% | 0.04% | -26.2% |
| Q2 2019 | $288,000 | -5.3% | 2,744 | +1.6% | 0.06% | +17.3% |
| Q4 2018 | $304,000 | -10.1% | 2,700 | +71.1% | 0.05% | +48.6% |
| Q3 2018 | $338,000 | -55.2% | 1,578 | -41.5% | 0.04% | -94.8% |
| Q2 2018 | $755,000 | -32.9% | 2,699 | -72.0% | 0.67% | -31.7% |
| Q1 2018 | $1,125,000 | +179.9% | 9,629 | +119.7% | 0.98% | +93.7% |
| Q4 2017 | $402,000 | – | 4,382 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |